Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma

Soft tissue sarcomas (STSs) are a rare cancer type. Almost half are unresponsive to multi‐pronged treatment and might therefore benefit from biologically targeted therapy. An emerging target is glycogen synthase kinase (GSK)3β, which is implicated in various diseases including cancer. Here, we inves...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Cancer Sci
Κύριοι συγγραφείς: Abe, Kensaku, Yamamoto, Norio, Domoto, Takahiro, Bolidong, Dilireba, Hayashi, Katsuhiro, Takeuchi, Akihiko, Miwa, Shinji, Igarashi, Kentaro, Inatani, Hiroyuki, Aoki, Yu, Higuchi, Takashi, Taniguchi, Yuta, Yonezawa, Hirotaka, Araki, Yoshihiro, Aiba, Hisaki, Minamoto, Toshinari, Tsuchiya, Hiroyuki
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2019
Θέματα:
Original Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004542/
https://ncbi.nlm.nih.gov/pubmed/31808966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14271
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια